# Hyperscale Data, Inc.: financial statements, quarterly

GPUS · NYSE · CIK 896493 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gpus.md) · [Financials](/companies/gpus/financials.md) · [Filings](/companies/gpus/filings.md) · [Insiders](/companies/gpus/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gpus/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [43.1](/filings/0001214659-24-019389.md) | [30.6 d](/filings/0001214659-25-005868.md) | [38.4](/filings/0001214659-25-008123.md) | [17.8](/filings/0001214659-25-012364.md) | [31.1](/filings/0001214659-25-016799.md) | [19.4 d](/filings/0001214659-26-004697.md) | [25.0](/filings/0001214659-26-006542.md) | [25.9](/filings/0001214659-26-010549.md) | [24.3](/filings/0001214659-25-016799.md) | [26.9 d](/filings/0001214659-26-004697.md) | [44.1](/filings/0001214659-26-006542.md) | [34.8](/filings/0001214659-26-010549.md) |
| Cost of revenue | $m | [34.4](/filings/0001214659-24-019389.md) | [45.2 d](/filings/0001214659-24-016683.md) | [25.4](/filings/0001214659-24-009647.md) | [29.0](/filings/0001214659-24-014883.md) | [22.5](/filings/0001214659-24-019389.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | [8.7](/filings/0001214659-24-019389.md) | [0.8 d](/filings/0001214659-25-005868.md) | [18.2](/filings/0001214659-25-008123.md) | [(3.8)](/filings/0001214659-25-012364.md) | [8.5](/filings/0001214659-25-016799.md) | [1.3 d](/filings/0001214659-26-004697.md) | [5.3](/filings/0001214659-26-006542.md) | [6.1](/filings/0001214659-26-010549.md) | [6.3](/filings/0001214659-25-016799.md) | [3.9 d](/filings/0001214659-26-004697.md) | [15.1](/filings/0001214659-26-006542.md) | [8.8](/filings/0001214659-26-010549.md) |
| Research and development | $m | [1.1](/filings/0001214659-24-019389.md) | [1.1 d](/filings/0001214659-25-005868.md) | [0.1](/filings/0001214659-25-008123.md) | [0.1](/filings/0001214659-25-012364.md) | [4.6](/filings/0001214659-25-016799.md) | [6.2 d](/filings/0001214659-26-004697.md) | [0.1](/filings/0001214659-26-006542.md) | [0.1](/filings/0001214659-26-010549.md) | [1.6](/filings/0001214659-25-016799.md) | [3.0 d](/filings/0001214659-26-004697.md) | [4.8](/filings/0001214659-26-006542.md) | [4.3](/filings/0001214659-26-010549.md) |
| Operating income | $m | [(20.4)](/filings/0001214659-24-019389.md) | [(52.1) d](/filings/0001214659-25-005868.md) | [3.7](/filings/0001214659-25-008123.md) | [(26.9)](/filings/0001214659-25-012364.md) | [(24.6)](/filings/0001214659-25-016799.md) | [(9.1) d](/filings/0001214659-26-004697.md) | [(6.4)](/filings/0001214659-26-006542.md) | [(10.1)](/filings/0001214659-26-010549.md) | [(14.1)](/filings/0001214659-25-016799.md) | [(31.7) d](/filings/0001214659-26-004697.md) | [(21.3)](/filings/0001214659-26-006542.md) | [(23.1)](/filings/0001214659-26-010549.md) |
| Interest expense | $m | [6.1](/filings/0001214659-24-019389.md) | [9.1 d](/filings/0001214659-25-005868.md) | [5.6](/filings/0001214659-25-008123.md) | [5.3](/filings/0001214659-25-012364.md) | [7.8](/filings/0001214659-25-016799.md) | [1.8 d](/filings/0001214659-26-004697.md) | [3.8](/filings/0001214659-26-006542.md) | [7.7](/filings/0001214659-26-010549.md) | [3.1](/filings/0001214659-25-016799.md) | [1.6 d](/filings/0001214659-26-004697.md) | [6.5](/filings/0001214659-26-006542.md) | [3.9](/filings/0001214659-26-010549.md) |
| Income tax | $m | [(0.6)](/filings/0001214659-24-019389.md) | [(0.2) d](/filings/0001214659-25-005868.md) | [(0.0)](/filings/0001214659-25-008123.md) | [(0.0)](/filings/0001214659-25-012364.md) | [0.1](/filings/0001214659-25-016799.md) | [0.0 d](/filings/0001214659-26-004697.md) | [0.1](/filings/0001214659-26-006542.md) | [(0.1)](/filings/0001214659-26-010549.md) | [0.3](/filings/0001214659-25-016799.md) | [0.1 d](/filings/0001214659-26-004697.md) | [0.2](/filings/0001214659-26-006542.md) | [(0.0)](/filings/0001214659-26-010549.md) |
| Net income | $m | [(21.8)](/filings/0001214659-24-019389.md) | [(99.9) d](/filings/0001214659-25-005868.md) | [3.7](/filings/0001214659-25-008123.md) | [(33.9)](/filings/0001214659-25-012364.md) | [(25.5)](/filings/0001214659-25-016799.md) | [(0.4) d](/filings/0001214659-26-004697.md) | [(4.2)](/filings/0001214659-26-006542.md) | [(19.1)](/filings/0001214659-26-010549.md) | [(13.0)](/filings/0001214659-25-016799.md) | [(30.1) d](/filings/0001214659-26-004697.md) | [(30.0)](/filings/0001214659-26-006542.md) | [(19.4)](/filings/0001214659-26-010549.md) |
| Diluted EPS | $ per share | [(99.48)](/filings/0001214659-24-019389.md) | not reported | [3.32](/filings/0001214659-25-008123.md) | [(37.81)](/filings/0001214659-25-012364.md) | [(24.82)](/filings/0001214659-25-016799.md) | not reported | [(0.98)](/filings/0001214659-26-006542.md) | [(2.66)](/filings/0001214659-26-010549.md) | [(0.39)](/filings/0001214659-25-016799.md) | not reported | [(0.09)](/filings/0001214659-26-006542.md) | [(0.05)](/filings/0001214659-26-010549.md) |
| Basic EPS | $ per share | [(99.48)](/filings/0001214659-24-019389.md) | not reported | [2.36](/filings/0001214659-25-008123.md) | [(37.81)](/filings/0001214659-25-012364.md) | [(24.82)](/filings/0001214659-25-016799.md) | not reported | [(0.98)](/filings/0001214659-26-006542.md) | [(2.66)](/filings/0001214659-26-010549.md) | [(0.39)](/filings/0001214659-25-016799.md) | not reported | [(0.09)](/filings/0001214659-26-006542.md) | [(0.05)](/filings/0001214659-26-010549.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [8.7](/filings/0001214659-23-015389.md) | [6.1](/filings/0001214659-25-005868.md) | [9.4](/filings/0001214659-24-009647.md) | [9.6](/filings/0001214659-24-014883.md) | [7.2](/filings/0001214659-24-019389.md) | [4.5](/filings/0001214659-26-004697.md) | [4.2](/filings/0001214659-25-008123.md) | [5.9](/filings/0001214659-25-012364.md) | [24.8](/filings/0001214659-25-016799.md) | [13.1](/filings/0001214659-26-010549.md) | [10.5](/filings/0001214659-26-006542.md) | [36.8](/filings/0001214659-26-010549.md) |
| Current assets | $m | [169](/filings/0001214659-23-015389.md) | [62.4](/filings/0001214659-25-005868.md) | [145](/filings/0001214659-24-009647.md) | [47.2](/filings/0001214659-24-014883.md) | [45.0](/filings/0001214659-24-019389.md) | [58.4](/filings/0001214659-26-004697.md) | [58.9](/filings/0001214659-25-008123.md) | [62.0](/filings/0001214659-25-012364.md) | [90.5](/filings/0001214659-25-016799.md) | [130](/filings/0001214659-26-010549.md) | [103](/filings/0001214659-26-006542.md) | [114](/filings/0001214659-26-010549.md) |
| Total assets | $m | [378](/filings/0001214659-23-015389.md) | [299](/filings/0001214659-25-005868.md) | [300](/filings/0001214659-24-009647.md) | [271](/filings/0001214659-24-014883.md) | [231](/filings/0001214659-24-019389.md) | [221](/filings/0001214659-26-004697.md) | [219](/filings/0001214659-25-008123.md) | [214](/filings/0001214659-25-012364.md) | [242](/filings/0001214659-25-016799.md) | [314](/filings/0001214659-26-010549.md) | [320](/filings/0001214659-26-006542.md) | [360](/filings/0001214659-26-010549.md) |
| Current liabilities | $m | [214](/filings/0001214659-23-015389.md) | [140](/filings/0001214659-25-005868.md) | [198](/filings/0001214659-24-009647.md) | [210](/filings/0001214659-24-014883.md) | [196](/filings/0001214659-24-019389.md) | [216](/filings/0001214659-26-004697.md) | [208](/filings/0001214659-25-008123.md) | [201](/filings/0001214659-25-012364.md) | [180](/filings/0001214659-25-016799.md) | [170](/filings/0001214659-26-010549.md) | [196](/filings/0001214659-26-006542.md) | [202](/filings/0001214659-26-010549.md) |
| Total liabilities | $m | [257](/filings/0001214659-23-015389.md) | [240](/filings/0001214659-25-005868.md) | [234](/filings/0001214659-24-009647.md) | [244](/filings/0001214659-24-014883.md) | [228](/filings/0001214659-24-019389.md) | [219](/filings/0001214659-26-004697.md) | [212](/filings/0001214659-25-008123.md) | [206](/filings/0001214659-25-012364.md) | [185](/filings/0001214659-25-016799.md) | [188](/filings/0001214659-26-010549.md) | [217](/filings/0001214659-26-006542.md) | [244](/filings/0001214659-26-010549.md) |
| Long-term debt | $m | [55.1](/filings/0001214659-23-015389.md) | [31.1](/filings/0001214659-24-016683.md) | [30.0](/filings/0001214659-24-009647.md) | [107](/filings/0001214659-24-014883.md) | [105](/filings/0001214659-24-019389.md) | [96.7](/filings/0001214659-25-005868.md) | [92.8](/filings/0001214659-25-008123.md) | [88.5](/filings/0001214659-25-012364.md) | [80.0](/filings/0001214659-25-016799.md) | [83.1](/filings/0001214659-26-004697.md) | [91.2](/filings/0001214659-26-006542.md) | [106](/filings/0001214659-26-010549.md) |
| Current portion of debt | $m | [21.8](/filings/0001214659-23-015389.md) | [0.9](/filings/0001214659-24-019389.md) | [0.2](/filings/0001214659-24-009647.md) | [0.2](/filings/0001214659-24-014883.md) | not reported | [19.6](/filings/0001214659-25-012364.md) | [22.9](/filings/0001214659-25-008123.md) | [21.8](/filings/0001214659-25-012364.md) | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [89.6](/filings/0001214659-23-015389.md) | [44.7](/filings/0001214659-25-005868.md) | [59.0](/filings/0001214659-24-009647.md) | [26.7](/filings/0001214659-24-014883.md) | [2.7](/filings/0001214659-24-019389.md) | [8.6](/filings/0001214659-26-004697.md) | [6.3](/filings/0001214659-25-008123.md) | [5.5](/filings/0001214659-25-012364.md) | [55.9](/filings/0001214659-25-016799.md) | [120](/filings/0001214659-26-010549.md) | [97.0](/filings/0001214659-26-006542.md) | [110](/filings/0001214659-26-010549.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(15.1) d](/filings/0001214659-24-019389.md) | [(3.3) d](/filings/0001214659-25-005868.md) | [(10.2)](/filings/0001214659-25-008123.md) | [(3.7) d](/filings/0001214659-25-012364.md) | [3.7 d](/filings/0001214659-25-016799.md) | [(9.2) d](/filings/0001214659-26-004697.md) | [(4.0)](/filings/0001214659-26-006542.md) | [(3.1) d](/filings/0001214659-26-010549.md) | [(17.8) d](/filings/0001214659-25-016799.md) | [(37.7) d](/filings/0001214659-26-004697.md) | [(0.2)](/filings/0001214659-26-006542.md) | [(9.7) d](/filings/0001214659-26-010549.md) |
| Capital expenditure | $m | [3.3 d](/filings/0001214659-24-019389.md) | [0.1 d](/filings/0001214659-25-005868.md) | [1.4](/filings/0001214659-25-008123.md) | [2.2 d](/filings/0001214659-25-012364.md) | [1.1 d](/filings/0001214659-25-016799.md) | [0.1 d](/filings/0001214659-26-004697.md) | [2.9](/filings/0001214659-26-006542.md) | [0.4 d](/filings/0001214659-26-010549.md) | [2.8 d](/filings/0001214659-25-016799.md) | [18.5 d](/filings/0001214659-26-004697.md) | [10.6](/filings/0001214659-26-006542.md) | [6.7 d](/filings/0001214659-26-010549.md) |
| Dividends paid | $m | [0.4 d](/filings/0001214659-24-019389.md) | [0.4 d](/filings/0001214659-25-005868.md) | [1.3](/filings/0001214659-25-008123.md) | [1.3 d](/filings/0001214659-25-012364.md) | [1.3 d](/filings/0001214659-25-016799.md) | [1.4 d](/filings/0001214659-26-004697.md) | [2.0](/filings/0001214659-26-006542.md) | [2.2 d](/filings/0001214659-26-010549.md) | [2.2 d](/filings/0001214659-25-016799.md) | [2.2 d](/filings/0001214659-26-004697.md) | [2.5](/filings/0001214659-26-006542.md) | [2.3 d](/filings/0001214659-26-010549.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1.0](/filings/0001214659-23-015389.md) | [0.0](/filings/0001214659-24-009647.md) | [0.0](/filings/0001214659-24-014883.md) | [0.2](/filings/0001214659-24-019389.md) | [1.0](/filings/0001214659-25-008123.md) | [0.9](/filings/0001214659-25-012364.md) | [1.1](/filings/0001214659-25-016799.md) | [6.3](/filings/0001214659-26-006542.md) | [8.0](/filings/0001214659-26-010549.md) | [38.8](/filings/0001214659-25-016799.md) | [381](/filings/0001214659-26-006542.md) | [475](/filings/0001214659-26-010549.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,529,995 at 2025-04-14, from the cover of the [10-K filed 2025-04-15](/filings/0001214659-25-005868.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.